Hong Kong’s Big Year for IPOs to Close With Final Rush of Deals


Those gauging investor interest this week include Shanghai-listed chip designer OmniVision Integrated Circuits Group Inc., which may raise as much as $1 billion, and drug-discovery company Insilico Medicine Inc., whose IPO may fetch about $300 million, people familiar with the deals said, asking not to be identified because they weren’t authorized to speak publicly. Shanghai Forest Cabin Cosmetics Group Co. is also gauging interest, according to terms of the deal seen by Bloomberg News.



Source link

  • Related Posts

    Rob Shaw: Questions linger over integrity of BC Conservative leadership race

    Candidate Peter Milobar seeks delay amid concerns over membership database Source link

    Trump Set to Deliver Rare Primetime Address About War With Iran

    IE 11 is not supported. For an optimal experience visit our site on another browser. Get an Inside Look at How Fiesta Tableware Products Are Made 05:00 More Americans Are…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Iran War: What a Marine Expeditionary Unit is – and other US military terms | US-Israel war on Iran News

    Iran War: What a Marine Expeditionary Unit is – and other US military terms | US-Israel war on Iran News

    Clarification: Trump-Supreme Court story – Loonie Politics

    Clarification: Trump-Supreme Court story – Loonie Politics

    In Europe, lobbyists are using soaring fuel prices to make the case for more dirty energy | World news

    In Europe, lobbyists are using soaring fuel prices to make the case for more dirty energy | World news

    Why the 787-10 uses fewer wheels than the A350-1000

    Why the 787-10 uses fewer wheels than the A350-1000

    Birthright citizenship case: Justices question administration’s ‘quirky’ arguments

    Birthright citizenship case: Justices question administration’s ‘quirky’ arguments

    MP rejects Palantir’s claims that criticism of NHS England deal is ‘ideologically motivated’ | Palantir

    MP rejects Palantir’s claims that criticism of NHS England deal is ‘ideologically motivated’ | Palantir